Physician profile
Marc Monte
NPI 1255327763
$1,872.47
in general payments reported to CMS, 2019-2025
38 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,486 · 2020: $359 · 2021: $27.67.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $240.00 | 2019-2020 | |
| Merck Sharp & Dohme LLC | $181.05 | 2019-2020 | |
| Daiichi Sankyo INC. | $142.31 | 2019-2020 | |
| E.R. Squibb & Sons, L.L.C. | $108.51 | 2019 | |
| Eisai INC. | $94.70 | 2019-2020 | |
| Astrazeneca Pharmaceuticals Lp | $91.37 | 2019-2020 | |
| Bayer Healthcare Pharmaceuticals INC. | $85.78 | 2019-2020 | |
| Celgene Corporation | $74.93 | 2019-2020 | |
| Novartis Pharmaceuticals Corporation | $64.15 | 2019-2020 | |
| Lilly USA, LLC | $55.95 | 2019 | |
| Janssen Biotech, INC. | $54.42 | 2019-2020 | |
| Amgen INC. | $54.06 | 2019 | |
| Puma Biotechnology, INC. | $47.25 | 2019 | |
| Portola Pharmaceuticals, LLC | $41.15 | 2019 | |
| Abbvie INC. | $40.53 | 2019 |
Show all 38 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $40.30 | 2019 | |
| Foundation Medicine, INC. | $39.28 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $32.15 | 2019 | |
| Pharmacyclics LLC, An Abbvie Company | $27.96 | 2019-2021 | |
| Rigel Pharmaceuticals, INC. | $26.39 | 2019-2020 | |
| Kyowa Kirin, INC. | $26.04 | 2019-2020 | |
| Array Biopharma INC | $25.46 | 2019-2020 | |
| Genzyme Corporation | $24.96 | 2019 | |
| Janssen Pharmaceuticals, INC | $24.32 | 2019 | |
| Collegium Pharmaceutical, INC. | $23.71 | 2019 | |
| Genentech USA, INC. | $23.65 | 2019 | |
| Amag Pharmaceuticals, INC. | $22.42 | 2019 | |
| Tolmar Pharmaceuticals, INC. | $18.74 | 2019 | |
| Clovis Oncology, INC. | $17.83 | 2019 | |
| Alexion Pharmaceuticals, INC. | $16.41 | 2019 | |
| Exelixis INC. | $16.22 | 2019 | |
| Dendreon Pharmaceuticals LLC | $15.02 | 2019 | |
| Seagen INC. | $14.53 | 2019 | |
| Emd Serono, INC. | $13.72 | 2019 | |
| Alnylam Pharmaceuticals INC. | $13.28 | 2020 | |
| Teva Pharmaceuticals USA, INC. | $12.90 | 2019 | |
| Gilead Sciences, INC. | $11.92 | 2021 | |
| Secura Bio, INC. | $9.10 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Marc Monte listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.